pharma companies working glp 1 GLP-1 2.0: Where the Next Wave of Value Will Be Created Compound versions of GLP-1 drugs

This overgrowth of pathogenic microorganisms crowds out beneficial flora, induces inflammation, and damages the GI tracts protective barrier

Rarely, individuals may experience dizziness or mild itching

The role of gut microbiota in the development of obesity and diabetes (in Eng)

Nevertheless, even the most effective marketed incretin, the GLP-1/GIP dual agonist tirzepatide, produces a maximum HbA1c reduction of ~2.6%, with fewer than half of participants in the SURPASS trials reaching normoglycemia (HbA1c 10%), vehicle-treated animals lost ~40% of body weight over 3 months, consistent with prior reports showing comparable reductions from ~40 g at week 10 to ~25 g by week 20 19

The KD may be especially beneficial in women with obesity and endometriosis, who often present with an altered metabolic phenotype with insulin resistance, chronic inflammation, and increased peripheral aromatization of androgens into estrogens in adipose tissue by aromatases